arrow
T

Toshitaka Odamaki

kyoto university
H指数:44
被引数:6,977

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Heat-Killed Bifidobacterium breve B-3, a Postbiotic, on Muscle Mass-Related Parameters in Patients with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

热灭活短双歧杆菌B-3(一种后生元)对肌少症患者肌肉质量相关参数的影响:一项随机、双盲、安慰剂对照的试点试验

2026-09-210
OA
Bifidobacterium longum subsp. infantis M-63 can reach the neonatal gut following World Health Organization-recommended infant formula preparation at ≥70 °C

婴儿双歧杆菌长亚种婴儿亚种M-63可在按照世界卫生组织推荐的≥70 °C婴儿配方奶制备方法后到达新生儿肠道

2026-09-080
OAAI
Bifidobacterium longum BB536 is associated with improvements in gastrointestinal symptoms and odor-related metabolites in microbiota-defined subgroups of male athletes consuming a high-protein diet: exploratory randomized double‑blind placebo‑controlled trial

长双歧杆菌BB536与男性高蛋白饮食运动员胃肠道症状和气味相关代谢物的改善相关:一项探索性随机双盲安慰剂对照试验

2026-04-270
OA
Sex-Specific Associations of Gut Microbiota Composition with Sarcopenia Defined by the Asian Working Group for Sarcopenia 2019 Consensus in Older Outpatients: Prospective Cross-Sectional Study in Japan

基于亚洲肌肉衰减症工作组2019年共识定义的老年门诊患者肠道菌群组成与肌肉衰减症的性别特异性关联:日本前瞻性横断面研究

2025-05-210
OA
In vitro competition with Bifidobacterium strains impairs potentially pathogenic growth of Clostridium perfringens on 2′-fucosyllactose

体外与双歧杆菌菌株的竞争会抑制产气荚膜梭菌在2'-岩藻糖基乳糖上的潜在致病性生长

2025-03-180
OAAI
The Impact of Fermented Milk Products Containing Bifidobacterium longum BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial

含长双歧杆菌BB536的发酵乳制品对肠道环境的影响: 一项随机双盲安慰剂对照试验

2024-10-220
OAAI
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan

人类肠道相关的双歧杆菌物种挽救外源吲哚,一种尿毒症毒素前体,通过色氨酸合成吲哚-3-乳酸

2024-05-054
OAAI